Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tsakos Energy Navigation

16.96
+0.22001.31%
Post-market: 16.960.00000.00%16:27 EDT
Volume:190.65K
Turnover:3.23M
Market Cap:510.96M
PE:3.37
High:17.10
Open:16.74
Low:16.73
Close:16.74
Loading ...

TEN Ltd. Reports Profits for the 12 Months and Fourth Quarter Ended December 31, 2024 and Announces Common Share Dividend

GlobeNewswire
·
27 Mar

New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings

Business Wire
·
26 Mar

REMINDER: Gas & Tankers Shipping Industry Leaders Presenting at Capital Link’s 19th Annual International Shipping Forum - Monday, March 31, 2025, New York City

GlobeNewswire
·
25 Mar

TEN Holdings, Inc. to Add Conversational AI Solutions to Service Portfolio

PR Newswire
·
24 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
24 Mar

Investing in Tsakos Energy Navigation (NYSE:TEN) three years ago would have delivered you a 119% gain

Simply Wall St.
·
20 Mar

TEN Holdings announces $1M stock repurchase program

TIPRANKS
·
19 Mar

TEN Holdings, Inc. Announces $1 Million Stock Repurchase Program

PR Newswire
·
19 Mar

Tsakos Energy Navigation Building DP2 Suezmax Shuttle Tankers for Petrobras Transporte Contracts

MT Newswires Live
·
18 Mar

TEN Ltd. Announces the Building of Nine DP2 Shuttle Tankers in South Korea With 15-Year Employment to Transpetro - Petrobras

GlobeNewswire
·
18 Mar

TEN, Ltd. Announces Date for the Fourth Quarter and Year End 2024 Results, Conference Call and Webcast

GlobeNewswire
·
14 Mar

Gas & Tankers Shipping Industry Leaders Presenting at Capital Link’s 19th Annual International Shipping Forum - Monday, March 31, 2025, New York City

GlobeNewswire
·
11 Mar

Sun Pharma to Acquire Checkpoint Therapeutics

PR Newswire
·
10 Mar

IMFINZI® (durvalumab)-based regimen demonstrated statistically significant and clinically meaningful improvement in event-free survival in resectable early-stage gastric and gastroesophageal junction cancers

Business Wire
·
07 Mar

Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma

Business Wire
·
07 Mar

TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy

Business Wire
·
04 Mar

TEN Holdings Initiated at Buy by Litchfield Hills

Dow Jones
·
04 Mar

TEN Holdings initiated with a Buy at Litchfield Hills

TIPRANKS
·
03 Mar

TEN Ltd. Announces the Passing of Industry Veteran and Long-Standing Chairman, Mr. John Stavropoulos

GlobeNewswire
·
28 Feb

Industry Leaders Presenting at Capital Link’s 19th Annual International Shipping Forum - Monday March 31, 2025, New York City

GlobeNewswire
·
26 Feb